196 related articles for article (PubMed ID: 16290106)
41. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
[TBL] [Abstract][Full Text] [Related]
42. Effects of the serotonin 5-HT(7) receptor antagonist SB-269970 on the inhibition of dopamine neuronal firing induced by amphetamine.
Mnie-Filali O; Dahan L; Zimmer L; Haddjeri N
Eur J Pharmacol; 2007 Sep; 570(1-3):72-6. PubMed ID: 17586491
[TBL] [Abstract][Full Text] [Related]
43. Prefrontal cortical up states are synchronized with ventral tegmental area activity.
Peters Y; Barnhardt NE; O'Donnell P
Synapse; 2004 May; 52(2):143-52. PubMed ID: 15034920
[TBL] [Abstract][Full Text] [Related]
44. Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin
Devroye C; Haddjeri N; Cathala A; Rovera R; Drago F; Piazza PV; Artigas F; Spampinato U
Neuropharmacology; 2017 Jun; 119():91-99. PubMed ID: 28390892
[TBL] [Abstract][Full Text] [Related]
45. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
Blackburn TP; Suzuki K; Ashby CR
Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
[TBL] [Abstract][Full Text] [Related]
46. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
47. In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release.
Casanovas JM; Berton O; Celada P; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):248-54. PubMed ID: 10997727
[TBL] [Abstract][Full Text] [Related]
48. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities.
Youn J; Misane I; Eriksson TM; Millan MJ; Ogren SO; Verhage M; Stiedl O
Neuropharmacology; 2009; 57(5-6):567-76. PubMed ID: 19607850
[TBL] [Abstract][Full Text] [Related]
49. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation.
Pistis M; Porcu G; Melis M; Diana M; Gessa GL
Eur J Neurosci; 2001 Jul; 14(1):96-102. PubMed ID: 11488953
[TBL] [Abstract][Full Text] [Related]
50. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex.
Amargós-Bosch M; Bortolozzi A; Puig MV; Serrats J; Adell A; Celada P; Toth M; Mengod G; Artigas F
Cereb Cortex; 2004 Mar; 14(3):281-99. PubMed ID: 14754868
[TBL] [Abstract][Full Text] [Related]
51. Optical imaging of rat prefrontal neuronal activity evoked by stimulation of the ventral tegmental area.
Watanabe Y; Kajiwara R; Takashima I
Neuroreport; 2009 Jun; 20(9):875-80. PubMed ID: 19417692
[TBL] [Abstract][Full Text] [Related]
52. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
[TBL] [Abstract][Full Text] [Related]
53. In vivo effect of 5-HT₇ receptor agonist on pyramidal neurons in medial frontal cortex of normal and 6-hydroxydopamine-lesioned rats: an electrophysiological study.
Fan LL; Zhang QJ; Liu J; Feng J; Gui ZH; Ali U; Zhang L; Hou C; Wang T; Hui YP; Sun YN; Wu ZH
Neuroscience; 2011 Sep; 190():328-38. PubMed ID: 21684321
[TBL] [Abstract][Full Text] [Related]
54. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
Matsubara K; Shimizu K; Suno M; Ogawa K; Awaya T; Yamada T; Noda T; Satomi M; Ohtaki K; Chiba K; Tasaki Y; Shiono H
Brain Res; 2006 Sep; 1112(1):126-33. PubMed ID: 16884702
[TBL] [Abstract][Full Text] [Related]
55. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.
El Mansari M; Ghanbari R; Janssen S; Blier P
Neuropharmacology; 2008 Dec; 55(7):1191-8. PubMed ID: 18708076
[TBL] [Abstract][Full Text] [Related]
56. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
Barrondo S; Sallés J
Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
[TBL] [Abstract][Full Text] [Related]
57. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
58. Dopamine modulates temporal dynamics of feedforward inhibition in rat prefrontal cortex in vivo.
Tierney PL; Thierry AM; Glowinski J; Deniau JM; Gioanni Y
Cereb Cortex; 2008 Oct; 18(10):2251-62. PubMed ID: 18222936
[TBL] [Abstract][Full Text] [Related]
59. In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease.
Wang S; Zhang QJ; Liu J; Ali U; Wu ZH; Chen L; Gui ZH; Wang Y; Hui YP
Exp Neurol; 2009 Sep; 219(1):239-48. PubMed ID: 19500571
[TBL] [Abstract][Full Text] [Related]
60. Quetiapine increases the firing rate of rat substantia nigra and ventral tegmental area dopamine neurons in vitro.
Werkman TR; Olijslagers JE; Perlstein B; Jansen AH; McCreary AC; Kruse CG; Wadman WJ
Eur J Pharmacol; 2004 Dec; 506(1):47-53. PubMed ID: 15588623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
